GSK/Novartis Consumer Healthcare joint venture acquired by GlaxoSmithKline plc
GlaxoSmithKline plc acquired GSK/Novartis Consumer Healthcare joint venture, a consumer healthcare brand, in Jun 2018.
Transaction summary
- Target
- GSK/Novartis Consumer Healthcare joint venture
- Acquirer
- GlaxoSmithKline plc
- Seller
- Novartis AG
- Announced
- 2018-03-27
- Completed
- 2018-06
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-10-18
- Latest update
- 2026-11-03
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Enterprise value is unavailable.
Source summary
Haleon 20-F, filed 2026-03-13
ConfirmedAcquisition of GSK/Novartis Consumer Healthcare joint venture by GlaxoSmithKline plc.
Open sourceHaleon 20-F, filed 2026-03-13
ConfirmedIn June 2018, GSK acquired Novartis’ shareholding in the GSK/Novartis JV for $13bn, enabling GSK to take full operational and strategic control of the business.
Open sourceHaleon 20-F, filed 2026-03-13
ConfirmedIn June 2018, GSK acquired Novartis’ shareholding in the GSK/Novartis JV for $13bn
Open sourceContinue your research
Related transaction comps
GSK Consumer Healthcare (Novartis 36.5% stake) receives investment from GlaxoSmithKline
2018-03-27 · Estimated
View transaction → Same buyer / investorPfizer Consumer Healthcare acquired by GlaxoSmithKline (GSK-Pfizer consumer joint venture)
2018-12-19 · Estimated
View transaction → Consumer HealthVitabiotics acquired by Bain Capital
2026-07-24 · Confirmed
View transaction → Consumer HealthZywie Ventures Private Limited (OZiva) acquired by Hindustan Unilever Limited (HUL)
2026-02-12 · Confirmed
View transaction →